0000912282-24-000697.txt : 20241009 0000912282-24-000697.hdr.sgml : 20241009 20241009165602 ACCESSION NUMBER: 0000912282-24-000697 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20241009 DATE AS OF CHANGE: 20241009 EFFECTIVENESS DATE: 20241009 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Alpha Cognition Inc. CENTRAL INDEX KEY: 0001655923 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 000000000 STATE OF INCORPORATION: A1 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-526363 FILM NUMBER: 241363207 BUSINESS ADDRESS: STREET 1: 1200-750 W PENDER ST CITY: VANCOUVER STATE: A1 ZIP: V6C 2T8 BUSINESS PHONE: (858) 344-4375 MAIL ADDRESS: STREET 1: 20073 FIDDLERS GREEN CITY: FRISCO STATE: TX ZIP: 75036 FORMER COMPANY: FORMER CONFORMED NAME: Neurodyn Cognition Inc. DATE OF NAME CHANGE: 20151016 D 1 primary_doc.xml X0708 D LIVE 0001655923 Alpha Cognition Inc. 1200 - 750 West Pender Street Vancouver A1 BRITISH COLUMBIA, CANADA V6C 2T8 (858) 344-4375 BRITISH COLUMBIA, CANADA Crystal Bridge Enterprises Inc. Neurodyn Cognition Inc. Corporation true Michael McFadden 1200 - 750 West Pender Street Vancouver A1 BRITISH COLUMBIA, CANADA V6C 2T8 Director Executive Officer Kenneth Cawkell 1200 - 750 West Pender Street Vancouver A1 BRITISH COLUMBIA, CANADA V6C 2T8 Director Executive Officer Rajeev Rob Bakshi 1200 - 750 West Pender Street Vancouver A1 BRITISH COLUMBIA, CANADA V6C 2T8 Director Len Mertz 1200 - 750 West Pender Street Vancouver A1 BRITISH COLUMBIA, CANADA V6C 2T8 Director John Havens 1200 - 750 West Pender Street Vancouver A1 BRITISH COLUMBIA, CANADA V6C 2T8 Director Phillip Mertz 1200 - 750 West Pender Street Vancouver A1 BRITISH COLUMBIA, CANADA V6C 2T8 Director Lauren D'Angelo 1200 - 750 West Pender Street Vancouver A1 BRITISH COLUMBIA, CANADA V6C 2T8 Executive Officer Jay Yoo 1200 - 750 West Pender Street Vancouver A1 BRITISH COLUMBIA, CANADA V6C 2T8 Executive Officer Biotechnology Decline to Disclose 06b false 2024-09-24 true true true true true true Senior Convertible Note Offering with Initial Warrants for Common Stock at price of $0.4220 per share equal to Note amount and Additional Warrants for Common Stock at price of $0.4220 per share equal to 50% of Note amount, exercisable until 9/24/2029 false 0 The Benchmark Company, LLC 22982 None None 150 E 58th Street, 17th Floor New York NY NEW YORK 10155 All States Spartan Capital Holdings, LLC 146251 None None 45 Broadway 19th Floor New York NY NEW YORK 10006 All States 11143857 4545000 6598857 Total amount remaining to be sold represents maximum potential exercise prices of warrants. false 22 360250 0 0 false Alpha Cognition Inc. /s/ Michael McFadden Michael McFadden Chief Executive Officer 2024-10-09